Trade Baxter International - BAX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 33.35 |
| Open | 33.29 |
| 1-Year Change | -20.28% |
| Day's Range | 33.29 - 33.91 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 33.78 | 0.41 | 1.23% | 33.37 | 33.96 | 33.07 |
| Feb 20, 2025 | 33.35 | 0.40 | 1.21% | 32.95 | 33.61 | 32.13 |
| Feb 19, 2025 | 30.73 | -0.35 | -1.13% | 31.08 | 31.13 | 30.52 |
| Feb 18, 2025 | 31.14 | 0.68 | 2.23% | 30.46 | 31.18 | 30.46 |
| Feb 14, 2025 | 30.76 | 0.32 | 1.05% | 30.44 | 30.97 | 30.44 |
| Feb 13, 2025 | 30.48 | 0.24 | 0.79% | 30.24 | 30.56 | 30.05 |
| Feb 12, 2025 | 30.15 | -0.04 | -0.13% | 30.19 | 30.43 | 29.83 |
| Feb 11, 2025 | 30.55 | -0.03 | -0.10% | 30.58 | 30.82 | 30.51 |
| Feb 10, 2025 | 30.76 | 0.19 | 0.62% | 30.57 | 30.79 | 30.40 |
| Feb 7, 2025 | 30.55 | -0.15 | -0.49% | 30.70 | 30.92 | 30.44 |
| Feb 6, 2025 | 30.73 | -0.57 | -1.82% | 31.30 | 31.51 | 30.73 |
| Feb 5, 2025 | 31.42 | 0.02 | 0.06% | 31.40 | 31.65 | 31.23 |
| Feb 4, 2025 | 31.37 | 0.19 | 0.61% | 31.18 | 31.53 | 31.16 |
| Feb 3, 2025 | 31.47 | -0.19 | -0.60% | 31.66 | 31.94 | 30.54 |
| Jan 31, 2025 | 32.51 | -0.28 | -0.85% | 32.79 | 33.12 | 32.45 |
| Jan 30, 2025 | 33.04 | 0.45 | 1.38% | 32.59 | 33.26 | 32.59 |
| Jan 29, 2025 | 32.72 | 0.29 | 0.89% | 32.43 | 32.92 | 32.43 |
| Jan 28, 2025 | 32.53 | -0.58 | -1.75% | 33.11 | 33.50 | 32.36 |
| Jan 27, 2025 | 33.40 | 0.87 | 2.67% | 32.53 | 33.52 | 32.50 |
| Jan 24, 2025 | 32.39 | 0.39 | 1.22% | 32.00 | 32.47 | 31.89 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Baxter Company profile
About Baxter International Inc
Baxter International Inc. through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Baxter International Inc revenues increased 10% to $12.78B. Net income increased 17% to $1.28B. Revenues reflect Americas segment increase of 10% to $6.67B, APAC segment increase of 13% to $2.79B. Net income benefited from Americas segment income increase of 17% to $2.61B, APAC segment income increase of 5% to $623M. Dividend per share increased from $0.96 to $1.09.
Equity composition
Common Stock $1 Par, 03/11, 2B auth., 683,494,944 issd., Less 112,110,796 Shs. in Treas. @$6.1M. Insiders control approx. 0.15%. PO 6/86, 1.85M shares @$18.75 by Goldman Sachs. *FY'98-'01 are restated for disc. ops. 5/01, 2-for-1 stock split. *5/02, Co acquired Fusion Medical Technologies @ 0.1763 (2,507,881 shs. issd.).
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Df2-1W
One Baxter Pkwy
DEERFIELD
ILLINOIS 60015
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com